Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CISD2 promotes the proliferation of glioma cells via suppressing beclin-1-mediated autophagy and is targeted by microRNA-449a

27 Sept 2017

Abstract excerpt

CDGSH iron sulfur domain 2 (CISD2) has been found to be important in carcinogenesis. However, the role of CISD2 in glioma remains to be elucidated. The present study aimed to investigate the role of CISD2 in glioma using the reverse transcription‑quantitative polymerase chain reaction, western blotting, co‑immunoprecipitation assay, immunofluorescence staining and other methods. The results demonstrated that the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to Metalloenzymes and iron-sulfur proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28983596
DOI: 10.3892/mmr.2017.7642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CISD2 promotes the proliferation of glioma cells via suppressing beclin-1-mediated autophagy and is targeted by microRNA-449aPMID 28983596Read ↗

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial DysfunctionSemantic proximity Read ↗

Downregulation of SETD8 by miR-382 is involved in glioma progressionSemantic proximity Read ↗

IGF2BP2 modulates autophagy and serves as a prognostic marker in gliomaSemantic proximity Read ↗

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.Semantic proximity Read ↗

RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting p38 MAPK signaling pathwaySemantic proximity Read ↗

PDCD2 as a prognostic biomarker in glioma correlates with malignant phenotypeSemantic proximity Read ↗

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for GliomaSemantic proximity Read ↗

CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCsSemantic proximity Read ↗

SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomesSemantic proximity Read ↗

Increased Expression of CDCA2 in Glioma Predicts Poor Prognosis as Identified by Population-based AnalysisSemantic proximity Read ↗

PDIA6 promotes glioma malignancy by activating the IRE1α- p-HSP27 signaling axisSemantic proximity Read ↗

Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.